Prevalence and Correlates of Psychotropic Medication Use among Adults with Developmental Disabilities: 1970–2000

Valdovinos, Maria G.; Schroeder, Stephen R.; Kim, Geunyoung

doi:10.1016/s0074-7750(03)01005-x

Cited by 18 publications

(9 citation statements)

References 92 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Greater age and lower level of functioning were associated with greater use of most medications, which is consistent with previous reports in ASD and developmental disabilities 678 WITWER AND LECAVALIER populations (Aman et al in press;Valdovinos et al 2003). One exception was that higher adaptive behavior scores were associated with greater stimulant use.…”

Section: Subject Characteristicssupporting

confidence: 90%

“…Valdovinos et al (2003) located 68 such studies in their review of the literature, from 1970 to 2000, but these were mainly done in individuals with mental retardation (MR). We were only able to locate four studies examining the prevalence and patterns of use of 672 WITWER AND LECAVALIER psychotropic medication in ASD populations (Aman et al 2003;Aman et al 1995;Langworthy-Lam et al 2002;Martin et al 1999).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Treatment Incidence and Patterns in Children and Adolescents with Autism Spectrum Disorders

Witwer¹,

Lecavalier²

2005

Journal of Child and Adolescent Psychopharmacology

111

View full text Add to dashboard Cite

This study examined the treatment rates and patterns in children and adolescents with autism spectrum disorders (ASDs). Data were collected on 353 nonreferred children and adolescents (mean age 9.5 +/- 3.9 years; range 3-21 years) with ASDs from public schools across Ohio. Parents provided information on the use of psychotropic medicines, vitamins, supplements, and modified diets. They also completed measures of social competence, problem behavior, and adaptive behavior. Results indicated that 46.7% of subjects had taken at least one psychotropic medication in the past year. In addition, 17.3% of subjects had taken some type of specially formulated vitamin or supplement, 15.5% were on a modified diet, 11.9% had some combination of psychotropic medication and an alternative treatment, and 4.8% had taken an anticonvulsant. Logistic regressions indicated that greater age, lower adaptive skills and social competence, and higher levels of problem behavior were associated with greater medication use. This was the first study to focus exclusively on a younger population, to survey patterns of modified diets, and to obtain standardized ratings of social competence, problem behaviors, and adaptive behavior in relation to medication use. The results of this study highlight the need for more research on psychotropic medication in children and adolescents with ASDs.

show abstract

Section: Subject Characteristicssupporting

confidence: 90%

Section: Introductionmentioning

confidence: 99%

Treatment Incidence and Patterns in Children and Adolescents with Autism Spectrum Disorders

Witwer¹,

Lecavalier²

2005

Journal of Child and Adolescent Psychopharmacology

111

View full text Add to dashboard Cite

show abstract

“…These authors looked at correlates of chemical restraint on variables, such as age, sex, level of intellectual disability, comorbid diagnoses and residential placement. A large percentage of studies, 38.5%, found no relationship between use of psychopharmacology and age; however, the remaining studies found a relationship with increasing age (19.2% of the sampled studies) and only one study found a significant correlation between decreased age and drug use (Valdovinos et al. 2003).…”

Section: Factors Correlating With Restraint Usementioning

confidence: 99%

“…Valdovinos et al. (2003) conducted a review of psychotropic drug use with people with intellectual disability from the years 1970 to 2000.…”

Section: Factors Correlating With Restraint Usementioning

confidence: 99%

Restraint Procedures and Challenging Behaviours in Intellectual Disability: An Analysis of Causative Factors

Matson

Boisjoli

2009

Research Intellect Disabil

View full text Add to dashboard Cite

Background Persons with intellectual disability often evince challenging behaviours. Efforts have been underway for some time to develop prosocial or positive skill acquisition treatments to address challenging behaviours. However, physical ⁄ mechanical and chemical restraint is still commonly used in many clinical and community settings. Such interventions may be planned or unplanned and in some cases implemented by staff ⁄ parents with little training. Method Physical ⁄ mechanical and chemical restraint and the factors that may result in the use and maintenance of restraint are reviewed. ResultsThe type, rate and intensity of challenging behaviours, and the age of the affected individual and residential placement appear to be among the major factors that put these persons at risk for restraint. Conclusions Restraint is still a commonly used intervention employed with people with challenging behaviours. Physical and chemical restraint should be used as a last resort, part of a planned programme, and implemented by trained people.

show abstract

“…Shifts in prescription patterns, however, have been observed with increases in combination treatments (both interclass and intraclass) and in the types of medications prescribed (Hβler, Thome, & Reis, 2015). Specifically, reported increases in the use of antipsychotics have been observed, from 23% in the 1990’s (Valdovinos, Schroeder, & Kim, 2003) to 45% reported in 2007 (Tsiouris et al, 2013) and antidepressants from 4.9% in the 1990’s (Valdovinos et al, 2003) to approximately 23% in 2007 (Tsiouris et al, 2013). …”

mentioning

confidence: 98%

Assessing the impact of psychotropic medication changes on challenging behavior of individuals with intellectual disabilities

Valdovinos

McMahon

Schieber

et al. 2016

International Journal of Developmental Disabilities

View full text Add to dashboard Cite

Objective The use of psychotropic medication to address challenging behavior in individuals diagnosed with intellectual disabilities is common practice; however, very few studies have examined how multiple medication use (or combination treatment) impacts the behaviors these medications are prescribed to treat. Method The current study followed eight individuals over a two-year period as they experienced changes in their psychotropic medication regimens. During that time, data from functional analyses and indirect assessments of challenging behavior were collected. Results The results suggest that changes in psychotropic medication regimens can produce changes in functional assessment outcomes, suggesting a need for continued behavioral assessment to better inform medication practices and behavioral treatment. Of the eight participants in the study, five participants’ behaviors varied in rate of responding in FAs across all medication changes. Additionally, three participants’ FAs produced changes in outcomes; however, those changes were not consistent across all medication changes, that is, not every medication change yielded different outcomes from previous assessments. Conclusion This study demonstrates how the outcome of an FA can be used to monitor the effects of psychotropic medication changes, specifically when medications are combined, on challenging behavior in individuals with intellectual and developmental disabilities.

show abstract

Prevalence and Correlates of Psychotropic Medication Use among Adults with Developmental Disabilities: 1970–2000

Cited by 18 publications

References 92 publications

Treatment Incidence and Patterns in Children and Adolescents with Autism Spectrum Disorders

Treatment Incidence and Patterns in Children and Adolescents with Autism Spectrum Disorders

Restraint Procedures and Challenging Behaviours in Intellectual Disability: An Analysis of Causative Factors

Assessing the impact of psychotropic medication changes on challenging behavior of individuals with intellectual disabilities

Contact Info

Product

Resources

About